| http://www.w3.org/ns/prov#value | - King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel branded prescription ph...Commonwealth Fund Case Study Points to 'Continuous Innovation' at Group Health Cooperative... urgent needs.
|
